您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [欧洲疾病预防控制中心&欧洲委员会&欧洲食品安全局]:ECDC/EC/EFSA访问塞尔维亚,以推进“一个健康”应对抗微生物耐药性的工作 - 发现报告

ECDC/EC/EFSA访问塞尔维亚,以推进“一个健康”应对抗微生物耐药性的工作

报告封面

INTERAGENCY ASSESSMENT ECDC/EC/EFSA country visit to Serbia toadvance One Health responses againstantimicrobial resistance 24−28 February 2025 The preparation of country visits to the Western Balkans is commissioned by ECDC to the consortium ofEpiconcept and Integrated Quality Laboratory Services with the financial support of the European Union underCN/39/409-781as part of contract ECDC/2022/006 on ‘Country support to advance One Health responses against This report was commissioned by ECDC, coordinated by Agnė Bajorinienė (ECDC) and produced by the consortiumrepresentatives Jean-Baptiste Ronat (Integrated Quality Laboratory Services) and Anthony Nardone (Epiconcept).The European Commission’s Directorate-General for Health and Food Safety (DG SANTE), European Food Safety Authors In alphabetical order: AgnėBajorinienė(ECDC), Carlo Gagliotti(Settore innovazione nei servizi sanitari e sociali, RegioneEmilia-Romagna, Italy), Anke Kohlenberg (ECDC), Aikaterini Mougkou (ECDC),Anthony Nardone (Epiconcept), Jean-BaptisteRonat(IQLS),representatives from the Directorate-General for Health and Food Safety(DG SANTE)of the European This report was sent for consultation to the Institute of Public Health Serbia and theVeterinary Directorateof theMinistry of Agriculture Forestry and Water Management of Serbia. Acknowledgements ECDC, DG SANTE, EFSA, Epiconcept and IQLS would like to thankDr Vera Stoiljković, Mersiha Omeragić, Ljubica Paković(Ministry of Health),Prof. Verica Jovanović, Dr Violeta Rakić, Dr Danijela Simić, Dr Vladan Šaponjić, Dr Dragana Plavša,MpharmLarisa Vujnović (Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”) andDrTatjana Labus(VeterinaryDirectorate, Ministry of Agriculture, Forestry and Water Management)for arranging the visit. Suggested citation: European Centre for Disease Prevention and Control. ECDC/EC/EFSA country visit to Serbia toadvance One Health responses against antimicrobial resistance 24−28 February 2025. Stockholm: ECDC; 2026. Stockholm, May 2026ISBN 978-92-9498-888-1doi10.2900/7142455Catalogue numberTQ-01-26-033-EN-N © European Centre for Disease Prevention and Control, 2026. Reproduction is authorised, provided the source isacknowledged. ii Contents Contents .................................................................................................................................................... iiiAbbreviations ............................................................................................................................................. ivSummary ....................................................................................................................................................1Introduction ................................................................................................................................................3Objectivesand scope ...................................................................................................................................3Background .................................................................................................................................................4Observations ...............................................................................................................................................5AMR strategies, action plans and coordination, based on a One Health approach..........................................5Human health aspects of antimicrobial resistance.......................................................................................5Animal health, food safety and environmental aspects ofantimicrobial resistance........................................10Conclusions ..............................................................................................................................................14 Abbreviations ALIMSAgency for Medicines and Medical Devices, SerbiaAMCAntimicrobial consumptionAMEGEuropean Medicines Agency’s Antimicrobial Advice Ad HocExpert GroupAMRAntimicrobial resistanceAMSAntimicrobial stewardshipASTAntimicrobial susceptibility testingATCAnatomical therapeutic classCAESARCentral Asian and European Surveillance of Antimicrobial Resistance networkCIACritically important antimicrobials for human medicineCOVID-19Coronavirus disease 2019CPDContinuous professional developmentCPECarbapenemase-producing EnterobacteralesCSFCerebrospinal fluidDDDDefined daily doseDG NEARDirectorate-General for Neighbourhood and Enlargement Negotiations (European Commission)DG SANTEDirectorate-General for Heath and Food Safety (European Commission)EAADEuropean Antibiotic Awareness DayEARS-NetEuropean Antimicrobial Resistance Surveillance NetworkECDCEuropean Centre for Disease Prevention and ControlECOFFEpidemiological cut-off values (from EUCAST)EEAEuropean Economic AreaEFSAEuropean Food Safety AuthorityEMAEuropean Medicines AgencyEQAExternal quality assessmentESBLExtended-spectrum beta-lactamaseESUAvetEuropean